If you find this podcast useful please give it a rating and review on iTunes by clicking here
Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
On today's Vox Markets Podcast: Paul Haywood, Chief Executive Officer of Block Energy (BLOE)
Paul Haywood, Chief Executive Officer of Block Energy (BLOE) on their initial production results from Norio field and the progress they are making at their West Rustavi field.
Block Energy (BLOE.L) is an AIM quoted oil and gas company with a growing portfolio of production, development and exploration assets in the Republic of Georgia. Block holds a 100% Working Interest in the producing Norio licence, a 90% interest in the producing Satskhenisi licence and a 25% interest in the West Rustavi licence with the right to farm-in to up to a 75% interest.
- Emmerson, Dev Clever Holdings and Chris Bailey
Justin WaiteDaily Podcast with Justin Waite20th Feb 2019On today's podcast: Emmerson discuss the appointment of potash processing expert. Dev Clever Holding explain their innovative, interactive and immersive technologies. Chris Bailey covers Sainsbury's, Lloyds & Glencore.
- SP Angel – Morning View – Wednesday 20 02 19 Dramatic deficit forecast even as palladium reaches new record
20th Feb 2019SP Angel morning look at commodities and miners, featuring: Anglo Asian Mining (AAZ LN) BUY – 96p (from 108p) – Earnings update Glencore (GLEN LN) – Glencore claim record EBITDA on strong copper mine performance Landore Resources (LND LN) – BAM Gold Preliminary Economic Assessment Pan African Resources (PAF LN) – Earnings climb as operations refocus on profitable ounces Transense Technologies plc (TRT LN) – 2nd mining contract announced this week for mining heavy truck tracking & tyre pressure monitoring
- Will further FDA discussions lead to approval for Motif Bio’s antibiotic Iclaprim?
20th Feb 2019In a conference call to investors and analysts, Motif Bio confirmed that the FDA had no questions over the clinical efficacy of Iclaprim. However the FDA stated it needs additional data to further evaluate the risk for liver toxicity before the NDA approval.
- 5 Things You Need To Know, Today, on Wednesday 20th February 2019
Justin Waite5 Things You Need To Know20th Feb 2019Five financial stories, trending today in a 70 second podcast, including: The number of people in work in the UK has continued to climb, with a record 32.6 million employed between October and December The jobless rate, remaining at 4%, is at its lowest since early 1975.
